CN Stock MarketDetailed Quotes

600329 Tianjin Pharmaceutical Da Ren Tang Group Corporation

Watchlist
  • 30.03
  • +0.25+0.84%
Market Closed Feb 26 15:00 CST
23.13BMarket Cap24.80P/E (TTM)

Tianjin Pharmaceutical Da Ren Tang Group Corporation Key Stats

Tianjin Pharmaceutical Da Ren Tang Group Corporation FY2024 Estimates Date

Currency:CNYMar 31, 2025

Estimate YoY
Revenue
8.72B
+6.11%
EPS
1.48
+15.23%
Strong Buy

Feb 26, 2025

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.544B--
Mar 31, 20252024/FY-- / 8.725B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.544B--
Mar 31, 20252024/FY-- / 8.725B--
Mar 30, 20242023/FY8.222B / 8.549B--
Mar 31, 20232022/FY8.249B / 7.337B--
Mar 31, 20212020/FY6.604B / 7.727B--

Unlock Free Earnings Estimates

Tianjin Pharmaceutical Da Ren Tang Group Corporation Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Feb 26, 2025

Strong Buy

  • Strong Buy

    66.67%
  • Buy

    33.33%
  • Hold

    0.00%
  • Underperform

    0.00%
  • Sell

    0.00%

Price Target

No Data